News

Read the latest news and updates from The Pirbright Institute.

Go to main content

Filters

Filters

Enter keywords

Select virus

Select month

Select researcher

Featured news

Pirbright and GALVmed partner to develop safer Rift Valley fever vaccine

The Pirbright Institute, through the Centre for Veterinary Vaccine Innovation and Manufacturing (CVIM), has entered into a new agreement with GALVmed to develop and deploy a safer and more effective Rift Valley fever (RVF) vaccine for use in low- and middle-income countries, particularly across…

Flock of sheep in a line on a dry landscape

Study highlights factors driving Crimean-Congo haemorrhagic fever in livestock

A study has revealed crucial insights into the transmission patterns and risk factors of Crimean-Congo haemorrhagic fever virus (CCHFV) in sheep, a natural host of the virus. Led by The Pirbright Institute and based on sequential observational studies and a multi site randomised trial conducted in…

Latest news

Young scientist shining a light on an egg in a green tray in a dark room.

CRISPR chicken cell study boosts potential for vaccine development

Scientists at The Pirbright Institute have created gene-edited chicken cells that produce significantly higher yields of influenza A virus and Newcastle disease virus (NDV). Poultry vaccines are the mainstay of disease prevention in the global poultry production industry, worth an estimated $420…